We are live on ! Find out more
ACM

Ashford Capital Management Portfolio holdings

AUM $809M
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+8.41%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.15%
5 Year Est. Return
+109.93%
10 Year Est. Return
+1,281.06%
AUM
$490M
AUM Growth
-$11.7M
Cap. Flow
-$32.2M
Cap. Flow %
-6.57%
Top 10 Hldgs %
29.59%
Holding
142
New
9
Increased
23
Reduced
56
Closed
16

Top Buys

Rank Stock Value
1
EBIX
Ebix Inc
EBIX
+$13.2M
2
SWI
SOLARWINDS INC COM STK (DE)
SWI
+$8.41M
3
AMAG
AMAG Pharmaceuticals
AMAG
+$6.11M
4
SUPN icon
Supernus Pharmaceuticals
SUPN
+$2.47M
5
NEWP
NEWPORT CORP
NEWP
+$2.27M

Top Sells

Rank Stock Value
1
EFII
Electronics for Imaging
EFII
+$9.58M
2
CLAR icon
Clarus
CLAR
+$6.18M
3
FOXF icon
Fox Factory Holding Corp
FOXF
+$4.23M
4
AXON
Axon Enterprise
AXON
+$3.9M
5
INCY icon
Incyte
INCY
+$3.8M

Sector Composition

Rank Sector Weight
1 Technology 28.05%
2 Industrials 14.77%
3 Healthcare 12.11%
4 Financials 10.34%
5 Materials 3.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGX icon
1
Argan
AGX
$7.98B
$23.1M 4.72%
639,981
+19,050
+3% +$621K
VICR icon
2
Vicor
VICR
$9.62B
$22.4M 4.56%
1,470,510
+106,100
+8% +$1.37M
LOGM
3
DELISTED
LogMein, Inc.
LOGM
$16.5M 3.37%
295,509
+1,000
+0.3% +$51.2K
EBIX
4
DELISTED
Ebix Inc
EBIX
$15.9M 3.25%
+523,837
New +$13.2M
CPRT icon
5
Copart
CPRT
$25.9B
$12.5M 2.54%
2,656,288
-11,600
-0.4% -$53.8K
MKTX icon
6
MarketAxess Holdings
MKTX
$4.15B
$12M 2.44%
144,580
-39,900
-22% -$3.16M
INCY icon
7
Incyte
INCY
$23.5B
$11.3M 2.31%
123,640
-45,930
-27% -$3.8M
SPY icon
8
State Street SPDR S&P 500 ETF Trust
SPY
$781B
$10.8M 2.19%
52,109
-16,936
-25% -$3.5M
MDCO
9
DELISTED
Medicines Co
MDCO
$10.4M 2.11%
369,950
+11,750
+3% +$330K
LFUS icon
10
Littelfuse
LFUS
$10.2B
$10.2M 2.09%
103,035
-1,450
-1% -$142K
NTCT icon
11
NETSCOUT
NTCT
$2.86B
$9.85M 2.01%
224,691
-52,050
-19% -$2.01M
NEWP
12
DELISTED
NEWPORT CORP
NEWP
$9.49M 1.94%
497,908
+117,400
+31% +$2.27M
FNGN
13
DELISTED
Financial Engines, Inc.
FNGN
$9.45M 1.93%
226,000
-1,100
-0.5% -$43.4K
PZA icon
14
Invesco National AMT-Free Municipal Bond ETF
PZA
$4.22B
$8.81M 1.8%
345,288
-86,796
-20% -$2.22M
SIVB
15
DELISTED
SVB Financial Group
SIVB
$8.7M 1.77%
68,489
-4,669
-6% -$558K
SWI
16
DELISTED
SOLARWINDS INC COM STK (DE)
SWI
$8.68M 1.77%
+169,400
New +$8.41M
CSGP icon
17
CoStar Group
CSGP
$11.3B
$8.66M 1.77%
437,850
-67,100
-13% -$1.27M
LGND icon
18
Ligand Pharmaceuticals
LGND
$6.02B
$8.29M 1.69%
172,379
-1,122
-0.6% -$43K
SUPN icon
19
Supernus Pharmaceuticals
SUPN
$2.68B
$8.22M 1.68%
679,987
+261,587
+63% +$2.47M
VRNT
20
DELISTED
Verint Systems
VRNT
$8.09M 1.65%
256,564
+9,422
+4% +$277K
FNV icon
21
Franco-Nevada
FNV
$41.4B
$7.95M 1.62%
163,694
+41,000
+33% +$2.13M
IHS
22
DELISTED
IHS INC CL-A COM STK
IHS
$7.74M 1.58%
68,035
-7,350
-10% -$849K
SPPI
23
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$7.66M 1.56%
1,261,162
+103,092
+9% +$686K
BCPC
24
Balchem Corp
BCPC
$5.23B
$7.25M 1.48%
130,907
-1,150
-0.9% -$65.8K
COO icon
25
Cooper Companies
COO
$13.7B
$7.11M 1.45%
151,640
+5,560
+4% +$235K
1
2 3 4 5

Similar funds

BDWCC
B&D White Capital Company Lakeway, Texas $809M AUM 19.33% 1-Year Est. Return
IPW
Impact Partnership Wealth Marietta, Georgia $810M AUM 13.94% 1-Year Est. Return
BWS
Buck Wealth Strategies Denver, Colorado $810M AUM 10.81% 1-Year Est. Return
SSG
Summit Securities Group New York $810M AUM 27.35% 1-Year Est. Return
BBI
Baxter Bros Inc Riverside, Connecticut $810M AUM 16.24% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return

Ashford Capital Management's Q1 2015 Portfolio in Review

As of Q1 2015, Ashford Capital Management held 142 positions worth $490M, down 2.3% from $502M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Ashford Capital Management withdrew a net $32.2M in Q1 2015, closing 16 positions and reducing 56 holdings. Its most notable exit was Clarus, an estimated $6.18M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 21% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Ashford Capital Management opened a new position in Ebix Inc worth $15.9M.

  • Ashford Capital Management's largest Q1 2015 buy was Ebix Inc: 523,837 shares worth $15.9M.
  • Ashford Capital Management added most to Supernus Pharmaceuticals in Q1 2015, an estimated $2.47M increase.
  • Ashford Capital Management's biggest Q1 2015 reduction was Electronics for Imaging, cutting an estimated $9.58M.
  • Ashford Capital Management fully exited Clarus in Q1 2015, selling an estimated $6.18M.
  • Ashford Capital Management's ten largest holdings make up 30% of its $490M portfolio in Q1 2015.
  • Ashford Capital Management opened 9 new positions and closed 16 in Q1 2015.
  • Ashford Capital Management's portfolio value fell 2.3% quarter-over-quarter to $490M.

Based on Ashford Capital Management's 13F filing for Q1 2015, filed 18 May 2015.